| Title |
Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
|
|---|---|
| Published in |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, October 2014
|
| DOI | 10.2147/dmso.s69520 |
| Pubmed ID | |
| Authors |
Carola A Huber, Peter Diem, Matthias Schwenkglenks, Roland Rapold, Oliver Reich |
| Abstract |
Estimating the prevalence of comorbidities and their associated costs in patients with diabetes is fundamental to optimizing health care management. This study assesses the prevalence and health care costs of comorbid conditions among patients with diabetes compared with patients without diabetes. Distinguishing potentially diabetes- and nondiabetes-related comorbidities in patients with diabetes, we also determined the most frequent chronic conditions and estimated their effect on costs across different health care settings in Switzerland. |
Mendeley readers
The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Canada | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 103 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 24 | 22% |
| Student > Master | 21 | 20% |
| Student > Ph. D. Student | 12 | 11% |
| Student > Bachelor | 11 | 10% |
| Other | 6 | 6% |
| Other | 14 | 13% |
| Unknown | 19 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 28% |
| Social Sciences | 7 | 7% |
| Nursing and Health Professions | 7 | 7% |
| Economics, Econometrics and Finance | 6 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
| Other | 22 | 21% |
| Unknown | 29 | 27% |